Copan Self Vaginal FLOQSwabs®:Agreement between clinician and self-collected samples for HPV detection. Evidence from the scientific literature

Stefania Di Costanzo, Cristiano Sabelli.

STIs and Self-Sampling: Copan’s Role in the Future of Sexually Transmitted Infections Prevention and Management

Stefania Di Costanzo, Ph.D., Scientific Affairs Manager

Preliminary Results of Feasibility and Acceptability ofSelf-Collection for Cervical Screening in Italian Women

Illari Sechi et al.

Source

Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer:implementation studies from five sub-Saharan African countries

Jessica Joseph et al.

Source

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study

Marianna Martinelli et al.

Source

Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program

Su Pei Khoo et al.

Source

Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs

Chiara Giubbi et al.

Source

Comparison of Different Self‐Sampling Devices for Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs): A Pilot Study

Ilaria Sechi et al.

Source